- Register TODAY! HDSA Research Webinar on GENERATION HD2
- Interested in learning more about clinical research? Visit HDTrialfinder.org
- Want to participate in research from home? Check out HDSA-vetted online studies
Register TODAY! HDSA Research Webinar on GENERATION HD2
Roche and Genentech have launched the GENERATION HD2 study of the huntingtin-lowering drug tominersen. Join HDSA on February 8th at 12PM ET as Roche/Genentech representatives Lauren Boak, Lifecycle Leader in Neurosciences and Rare Diseases, and Dr. Peter McColgan, Clinical Science Leader, speak about the study and address community questions. Click here to register today.
Interested in learning more about clinical research? Visit HDTrialfinder.org
While we await updates directly from Roch in HDSA’s February research webinar, there are plenty of other HD research studies in which people affected by HD and their family members can get involved. If you or your loved ones are interested in participating in HD research, or you just want to learn more about what studies are happening in HD, visit HDTrialfinder.org. If you are interested in learning more about what studies are currently happening in HD and what’s coming up next, check out the HD Research Pipeline page in HDSA’s website.
Want to participate in research from home? Check out HDSA-vetted online studies
The clinical research studies that often make HD News headlines are ones that explore whether compounds can safely treat or cure HD. But, there are dozens of other HD research studies that are looking to determine best practices in HD care, understand the experiences of HD caregivers, assess decision-making tactics of individuals considering genetic testing, and more. The best part? Many of these studies can be completed from home! To learn more about online surveys that have been vetted by HDSA, click here.